|
DNM1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72173386658869E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83508763740292E-12 |
| Normal-vs-Stage2 |
8.190700E-04 |
| Normal-vs-Stage3 |
3.58346685658262E-12 |
| Normal-vs-Stage4 |
1.97386551548107E-12 |
| Stage1-vs-Stage2 |
3.058100E-02 |
| Stage1-vs-Stage3 |
8.758200E-02 |
| Stage1-vs-Stage4 |
1.170000E-02 |
| Stage2-vs-Stage3 |
4.221500E-03 |
| Stage2-vs-Stage4 |
1.120720E-03 |
| Stage3-vs-Stage4 |
4.456800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09832151654155E-14 |
| Normal-vs-AfricanAmerican |
9.033500E-04 |
| Normal-vs-Asian |
6.76670000032686E-08 |
| Caucasian-vs-AfricanAmerican |
9.555700E-02 |
| Caucasian-vs-Asian |
4.923800E-01 |
| AfricanAmerican-vs-Asian |
3.008600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.49959991278126E-10 |
| Normal-vs-Female |
1.73383529755711E-12 |
| Male-vs-Female |
5.384400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.16393569729689E-12 |
| Normal-vs-Age(41-60Yrs) |
1.17269971511291E-10 |
| Normal-vs-Age(61-80Yrs) |
1.88159998693038E-09 |
| Normal-vs-Age(81-100Yrs) |
2.976000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.096400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.025200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.226600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.126600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.526800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.378000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.855400E-03 |
| Classical-VS-Follicular |
2.166200E-01 |
| Classical-VS-Other |
5.594600E-01 |
| Classical-VS-Normal |
3.62276875165435E-12 |
| Tall-VS-Follicular |
1.260560E-03 |
| Tall-VS-Other |
4.169000E-01 |
| Tall-VS-Normal |
2.33870034449524E-10 |
| Follicular-VS-Other |
3.827200E-01 |
| Follicular-VS-Normal |
1.58517999999663E-05 |
| Other-VS-Normal |
1.963910E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.20850054594757E-11 |
| Normal-vs-N1 |
1.05400022043511E-10 |
| N0-vs-N1 |
2.265800E-01 |
|
|
